Skip to main content

Advertisement

SpringerLink
Log in

Exposure to anticholinergic and sedative medicines as indicators of high-risk prescriptions in the elderly

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background There are several assessment scales to evaluate the risk of falls or the adverse drug reaction risk. Few are sufficiently specific to assess the impact of drug prescriptions on falls in geriatric populations. Objective To define the risk of anticholinergic and sedation-related ADRs in an elderly hospitalized patient population using the Drug Burden Index (DBI), Anticholinergic Drug Scale (ADS), and Sedative Load Model (SLM). Setting Five geriatric university hospital centers in France. Method Multicenter prospective cohort study from 2011 to 2013. Drug prescriptions were compiled to estimate anticholinergic and sedative exposure. Any associations between the drug scales and falls were assessed. Main outcome measure Drug exposure estimated with the DBI, ADS, and SLM scales. Results 315 patients, with a mean age of 87 years and 117 documented falls, were included from 5 geriatric hospitals. Sixty-one percent of these patients had a DBI > 0, 20.3% had an ADS ≥ 3, 56.2% a SLM > 0. No association was detected between the scores and the risk of a fall (p > 0.05). Factors significantly associated with a risk of a fall were: a prior history of a fall in the previous 12 months (adjusted odds ratio [aOR] = 7.24, 4.06–12.89), orthostatic hypotension ([aOR] = 2.84; 1.39–5.79), or prescription of antidepressants ([aOR] = 2.12; 1.17–3.84). Conclusion A specific scale to identify high-risk prescriptions would help clinicians and pharmacists to optimize therapeutic treatments for the elderly. In light of the multifactorial characteristics of falls, predicting their risk should be based on a well-defined set of factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Platten HP, Schweizer E, Dilger K, Mikus G, Klotz U. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther. 1998;63(5):552–60.

    Article  CAS  PubMed  Google Scholar 

  3. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ Can Med Assoc J J Assoc Med Can. 2005;173(5):489–95.

    Article  Google Scholar 

  4. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.

    Article  PubMed  Google Scholar 

  5. Marcum ZA, Arbogast KL, Behrens MC, Logsdon MW, Francis SD, Jeffery SM, et al. Utility of an adverse drug event trigger tool in Veterans Affairs nursing facilities. Consult Pharm J Am Soc Consult Pharm. 2013;28(2):99–109.

    Article  Google Scholar 

  6. Berdot S, Bertrand M, Dartigues J-F, Fourrier A, Tavernier B, Ritchie K, et al. Inappropriate medication use and risk of falls—A prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 2009;9(1):30.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55(5):780–91.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA. 1995;273(17):1348–53.

    Article  CAS  PubMed  Google Scholar 

  9. Searle SD, Rockwood K. Frailty and the risk of cognitive impairment. Alzheimers Res Ther. 2015;7(1):54.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319(26):1701–7.

    Article  CAS  PubMed  Google Scholar 

  11. Tinetti ME, Baker DI, McAvay G, Claus EB, Garrett P, Gottschalk M, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med. 1994;331(13):821–7.

    Article  CAS  PubMed  Google Scholar 

  12. Panel on Prevention of Falls in Older Persons AGS and BGS. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011;59(1):148–57.

  13. Kashyap M, Belleville S, Mulsant BH, Hilmer SN, Paquette A, Tu LM, et al. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc. 2014;62(2):336–41.

    Article  PubMed  Google Scholar 

  14. Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–7.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Dunn JE, Rudberg MA, Furner SE, Cassel CK. Mortality, disability, and falls in older persons: the role of underlying disease and disability. Am J Public Health. 1992;82(3):395–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Salahudeen MS, Duffull SB, Nishtala PS. Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review. Drugs Aging. 2014;31(3):185–92.

    Article  CAS  PubMed  Google Scholar 

  17. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30–9.

    Article  CAS  PubMed  Google Scholar 

  18. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.

    Article  PubMed  Google Scholar 

  19. Rotta I, Salgado TM, Silva ML, Correr CJ, Fernandez-Llimos F. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010). Int J Clin Pharm. 2015;37(5):687–97.

    Article  CAS  PubMed  Google Scholar 

  20. Sloane P, Ivey J, Roth M, Roederer M, Williams CS. Accounting for the sedative and analgesic effects of medication changes during patient participation in clinical research studies: measurement development and application to a sample of institutionalized geriatric patients. Contemp Clin Trials. 2008;29(2):140–8.

    Article  PubMed  Google Scholar 

  21. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivelä S-L, Isoaho R. A model to classify the sedative load of drugs. Int J Geriatr Psychiatry. 2003;18(6):542–4.

    Article  CAS  PubMed  Google Scholar 

  22. Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481–6.

    Article  CAS  PubMed  Google Scholar 

  23. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–13.

    Article  PubMed  Google Scholar 

  24. Lönnroos DE, Gnjidic D, Hilmer SN, Bell JS, Kautiainen H, Sulkava R, et al. Drug Burden Index and hospitalization among community-dwelling older people. Drugs Aging. 2012;29(5):395–404.

    Article  PubMed  Google Scholar 

  25. Wilson NM, Hilmer SN, March LM, Chen JS, Gnjidic D, Mason RS, et al. Associations between drug burden index and mortality in older people in residential aged care facilities. Drugs Aging. 2012;29(2):157–65.

    Article  PubMed  Google Scholar 

  26. Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753–8.

    Article  PubMed  Google Scholar 

  27. Dauphinot V, Faure R, Omrani S, Goutelle S, Bourguignon L, Krolak-Salmon P, et al. Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort. J Clin Psychopharmacol. 2014;34(5):565–70.

    Article  CAS  PubMed  Google Scholar 

  28. Oliver D, Britton M, Seed P, Martin FC, Hopper AH. Development and evaluation of evidence based risk assessment tool (STRATIFY) to predict which elderly inpatients will fall: case-control and cohort studies. BMJ. 1997;315(7115):1049–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bongue B, Laroche ML, Gutton S, Colvez A, Guéguen R, Moulin JJ, et al. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. Eur J Clin Pharmacol. 2011;67(12):1291–9.

    Article  CAS  PubMed  Google Scholar 

  30. Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–7.

    Article  PubMed  Google Scholar 

  31. Faure R, Dauphinot V, Krolak-Salmon P, Mouchoux C. A standard international version of the Drug Burden Index for cross-national comparison of the functional burden of medications in older people. J Am Geriatr Soc. 2013;61(7):1227–8.

    Article  PubMed  Google Scholar 

  32. Nakamura T, Meguro K, Sasaki H. Relationship between falls and stride length variability in senile dementia of the Alzheimer type. Gerontology. 1996;42(2):108–13.

    Article  CAS  PubMed  Google Scholar 

  33. Bongue B, Dupré C, Beauchet O, Rossat A, Fantino B, Colvez A. A screening tool with five risk factors was developed for fall-risk prediction in community-dwelling elderly. J Clin Epidemiol. 2011;64(10):1152–60.

    Article  PubMed  Google Scholar 

  34. Hnizdo S, Archuleta RA, Taylor B, Kim SC. Validity and reliability of the modified John Hopkins Fall Risk Assessment Tool for elderly patients in home health care. Geriatr Nurs N Y N. 2013;34(5):423–7.

    Article  Google Scholar 

  35. Barker AL, Nitz JC, Low Choy NL, Haines T. Measuring fall risk and predicting who will fall: clinimetric properties of four fall risk assessment tools for residential aged care. J Gerontol A Biol Sci Med Sci. 2009;64(8):916–24.

    Article  PubMed  Google Scholar 

  36. Sherrington C, Lord SR, Close JCT, Barraclough E, Taylor M, O’Rourke S, et al. A simple tool predicted probability of falling after aged care inpatient rehabilitation. J Clin Epidemiol. 2011;64(7):779–86.

    Article  PubMed  Google Scholar 

  37. Tiedemann A, Sherrington C, Orr T, Hallen J, Lewis D, Kelly A, et al. Identifying older people at high risk of future falls: development and validation of a screening tool for use in emergency departments. Emerg Med J EMJ. 2013;30(11):918–22.

    Article  PubMed  Google Scholar 

  38. Russell MA, Hill KD, Day LM, Blackberry I, Gurrin LC, Dharmage SC. Development of the Falls Risk for Older People in the Community (FROP-Com) screening tool. Age Ageing. 2009;38(1):40–6.

    Article  PubMed  Google Scholar 

  39. Buatois S, Perret-Guillaume C, Gueguen R, Miget P, Vançon G, Perrin P, et al. A simple clinical scale to stratify risk of recurrent falls in community-dwelling adults aged 65 years and older. Phys Ther. 2010;90(4):550–60.

    Article  PubMed  Google Scholar 

  40. Billington J, Fahey T, Galvin R. Diagnostic accuracy of the STRATIFY clinical prediction rule for falls: a systematic review and meta-analysis. BMC Fam Pract. 2012;7(13):76.

    Article  Google Scholar 

  41. Rojas-Fernandez CH, Seymour N, Brown SG. Helping pharmacists to reduce fall risk in long-term care: a clinical tool to facilitate the medication review process. Can Pharm J CPJ Rev Pharm Can RPC. 2014;147(3):171–8.

    Article  Google Scholar 

  42. da Costa BR, Rutjes AWS, Mendy A, Freund-Heritage R, Vieira ER. Can falls risk prediction tools correctly identify fall-prone elderly rehabilitation inpatients? A systematic review and meta-analysis. PLoS ONE. 2012;7(7):e41061.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Narayan SW, Hilmer SN, Horsburgh S, Nishtala PS. Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging. 2013;30(11):927–34.

    Article  CAS  PubMed  Google Scholar 

  44. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.

    Article  PubMed  Google Scholar 

  45. Kerse N, Flicker L, Pfaff JJ, Draper B, Lautenschlager NT, Sim M, et al. Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS ONE. 2008;3(6):e2423.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Payne RA, Abel GA, Simpson CR, Maxwell SRJ. Association between prescribing of cardiovascular and psychotropic medications and hospital admission for falls or fractures. Drugs Aging. 2013;30(4):247–54.

    Article  PubMed  Google Scholar 

  47. Richardson K, Bennett K, Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing. 2015;44(1):90–6.

    Article  PubMed  Google Scholar 

  48. Linjakumpu TA, Hartikainen SA, Klaukka TJ, Koponen HJ, Hakko HH, Viilo KM, et al. Sedative drug use in the home-dwelling elderly. Ann Pharmacother. 2004;38(12):2017–22.

    Article  PubMed  Google Scholar 

  49. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001;49(12):1685–90.

    Article  CAS  PubMed  Google Scholar 

  50. Kouladjian L, Gnjidic D, Chen TF, Mangoni AA, Hilmer SN. Drug Burden Index in older adults: theoretical and practical issues. Clin Interv Aging. 2014;9(9):1503–15.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the collaborators of the IPR group who participated in the study.

Funding

The IPR study is funded by the National French Program of Hospital Quality Research (Programme de Recherche en Qualité Hospitalière).

Conflicts of interest

The authors declare no relevant conflicts of interest or financial relationship.

Author information

Authors and Affiliations

  1. Pharmacy, Charpennes Hospital Center, Hospices Civils de Lyon, 27, rue Gabriel-Péri, 69100, Villeurbanne, France

    Elodie Jean-Bart & Christelle Mouchoux

  2. Clinical Research Centre (CRC) - VCF (Aging - Brain - Frailty), Charpennes Hospital, University Hospital of Lyon, Villeurbanne, France

    Elodie Jean-Bart, Claire Moutet, Pierre Krolak-Salmon & Christelle Mouchoux

  3. Clinical and Research Memory Center of Lyon, Charpennes Hospital, Hospices Civils de Lyon, Villeurbanne, France

    Pierre Krolak-Salmon

  4. Brain Dynamics and Cognition, Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR 5292, Lyon, France

    Pierre Krolak-Salmon & Christelle Mouchoux

  5. University Lyon 1, Lyon, France

    Virginie Dauphinot, Pierre Krolak-Salmon & Christelle Mouchoux

Authors
  1. Elodie Jean-Bart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire Moutet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Virginie Dauphinot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pierre Krolak-Salmon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christelle Mouchoux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elodie Jean-Bart.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jean-Bart, E., Moutet, C., Dauphinot, V. et al. Exposure to anticholinergic and sedative medicines as indicators of high-risk prescriptions in the elderly. Int J Clin Pharm 39, 1237–1247 (2017). https://doi.org/10.1007/s11096-017-0533-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-017-0533-4

Keywords

Search

Navigation